|
DE286509C
(enExample)
|
|
|
|
|
|
DE257197C
(enExample)
|
|
|
|
|
|
US3914252A
(en)
|
1971-03-15 |
1975-10-21 |
Continental Oil Co |
Preparation of N-iodocompounds
|
|
DD257197A1
(de)
|
1987-01-28 |
1988-06-08 |
Univ Dresden Tech |
Verfahren zur herstellung von immobilisierten, in ihrer biologischen aktivitaet stabilisierten und in ihren pharmakologischen eigenschaften modifizierten insulinpraeparationen
|
|
DK105489D0
(da)
|
1989-03-03 |
1989-03-03 |
Novo Nordisk As |
Polypeptid
|
|
DD286509A5
(de)
|
1989-06-30 |
1991-01-31 |
Veb Berlin-Chemie,De |
Verfahren zur herstellung von aktivitaetsstabilisierten, wirkungsverlaengerten rektal applizierbaren insulinpraeparationen
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
DE69129154T2
(de)
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
US6500645B1
(en)
|
1994-06-17 |
2002-12-31 |
Novo Nordisk A/S |
N-terminally extended proteins expressed in yeast
|
|
ZA954983B
(en)
|
1994-06-17 |
1996-02-14 |
Novo Nordisk As |
N-terminally extended proteins expressed in yeast
|
|
ATE455171T1
(de)
|
1995-09-21 |
2010-01-15 |
Genentech Inc |
Varianten des menschlichen wachstumshormons
|
|
WO1998022577A1
(en)
|
1996-11-15 |
1998-05-28 |
Maria Grazia Masucci |
Fusion proteins having increased half-lives
|
|
ATE317443T1
(de)
|
1996-12-20 |
2006-02-15 |
Novo Nordisk As |
N-terminal verlängerte proteine exprimiert in hefe
|
|
ATE375363T1
(de)
|
1997-07-14 |
2007-10-15 |
Bolder Biotechnology Inc |
Derivate des wachstumshormons und verwandte proteine
|
|
ATE407697T1
(de)
|
1999-07-13 |
2008-09-15 |
Bolder Biotechnology Inc |
Erythropoietin immunglobulin fusionsproteine
|
|
US20050287153A1
(en)
|
2002-06-28 |
2005-12-29 |
Genentech, Inc. |
Serum albumin binding peptides for tumor targeting
|
|
US7608681B2
(en)
|
1999-12-24 |
2009-10-27 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
US20060183197A1
(en)
|
2001-01-11 |
2006-08-17 |
Andersen Kim V |
Variant growth hormone molecules conjugated with macromolecules compounds
|
|
JP2004524020A
(ja)
|
2001-01-11 |
2004-08-12 |
マキシゲン・エイピーエス |
改良された成長ホルモン分子
|
|
US20020169125A1
(en)
|
2001-03-21 |
2002-11-14 |
Cell Therapeutics, Inc. |
Recombinant production of polyanionic polymers and uses thereof
|
|
AU2002341215A1
(en)
|
2001-11-12 |
2003-05-26 |
University Of Wales College Of Medicine |
Growth hormone variations in humans and their uses
|
|
GB2384001B
(en)
|
2001-12-14 |
2004-02-04 |
Asterion Ltd |
Chimeric growth hormone-growth hormone receptor proteins
|
|
CA2832136C
(en)
|
2002-09-27 |
2015-11-17 |
Xencor |
Optimized fc variants and methods for their generation
|
|
US20040180054A1
(en)
|
2003-03-13 |
2004-09-16 |
Hanmi Pharm. Co., Ltd. |
Physiologically active polypeptide conjugate having prolonged in vivo half-life
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
BRPI0406605B8
(pt)
|
2003-11-13 |
2021-05-25 |
Hanmi Holdings Co Ltd |
conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo
|
|
KR100594607B1
(ko)
|
2004-11-03 |
2006-06-30 |
재단법인서울대학교산학협력재단 |
신규한 경구투여용 재조합 인간 성장호르몬 분비미생물제제 및 그 제조방법
|
|
US7998930B2
(en)
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
|
CN101111516B
(zh)
*
|
2005-01-25 |
2013-02-27 |
细胞治疗学公司 |
体内半衰期改变的生物活性蛋白质偶联物
|
|
CA2595695A1
(en)
*
|
2005-01-25 |
2006-08-03 |
Cell Therapeutics, Inc. |
Biologically active protein conjugates comprising (nn[s/t]) peptide repeats and having increased plasma half-life
|
|
US20090036353A1
(en)
|
2005-01-27 |
2009-02-05 |
Novo Nordisk A/S |
Insulin Derivatives Conjugated with Structurally Well Defined Branched Polymers
|
|
MX2007009906A
(es)
|
2005-02-16 |
2007-09-25 |
Novo Nordisk As |
Derivados de agentes insulinotropicos conjugados con polimeros ramificados estructuralmente bien definidos.
|
|
KR100754667B1
(ko)
|
2005-04-08 |
2007-09-03 |
한미약품 주식회사 |
비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
|
|
CA2606102C
(en)
|
2005-04-26 |
2014-09-30 |
Medimmune, Inc. |
Modulation of antibody effector function by hinge domain engineering
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
US8492129B2
(en)
|
2005-12-12 |
2013-07-23 |
Innova Biosciences, Ltd. |
Production of conjugates
|
|
EP1971355B1
(en)
|
2005-12-20 |
2020-03-11 |
Duke University |
Methods and compositions for delivering active agents with enhanced pharmacological properties
|
|
CA2644712C
(en)
|
2006-03-06 |
2016-09-13 |
Amunix, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
WO2008019368A2
(en)
|
2006-08-07 |
2008-02-14 |
Teva Biopharmaceuticals Usa, Inc. |
Albumin-insulin fusion proteins
|
|
WO2008052108A2
(en)
|
2006-10-26 |
2008-05-02 |
Centocor Ortho Biotech Inc. |
Methods for use in human-adapting monoclonal antibodies
|
|
WO2008049711A1
(en)
*
|
2006-10-27 |
2008-05-02 |
Novo Nordisk A/S |
Peptide extended insulins
|
|
US20100303723A1
(en)
|
2006-11-20 |
2010-12-02 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
|
WO2008092117A2
(en)
|
2007-01-25 |
2008-07-31 |
Xencor, Inc. |
Immunoglobulins with modifications in the fcr binding region
|
|
KR20080095141A
(ko)
|
2007-04-23 |
2008-10-28 |
포항공과대학교 산학협력단 |
인간 알부민 링커를 통하여 면역글로불린의 Ｆｃ에 결합된생리학적 활성 폴리펩티드의 융합 폴리펩티드, 및 이의제조방법
|
|
CN101687933B
(zh)
|
2007-05-30 |
2015-11-25 |
浦项工科大学校产学协力团 |
免疫球蛋白融合蛋白
|
|
AU2008255352B2
(en)
|
2007-05-31 |
2014-05-22 |
Genmab A/S |
Stable IgG4 antibodies
|
|
WO2009015345A1
(en)
|
2007-07-25 |
2009-01-29 |
Amgen Inc. |
Pharmaceutical compositions comprising fc fusion proteins
|
|
CA2695374A1
(en)
*
|
2007-08-15 |
2009-02-19 |
Amunix, Inc. |
Compositions and methods for modifying properties of biologically active polypeptides
|
|
WO2009053368A1
(en)
|
2007-10-22 |
2009-04-30 |
Merck Serono S.A. |
Single ifn-beta fused to a mutated igg fc fragment
|
|
CN106822891A
(zh)
|
2008-06-20 |
2017-06-13 |
诺华公司 |
具有降低的聚集的免疫球蛋白
|
|
WO2010001196A1
(en)
|
2008-07-02 |
2010-01-07 |
Koninklijke Philips Electronics N.V. |
V-spring configuration and end attachment assemblies therefor for use in a personal care appliance
|
|
EP2300501B1
(en)
|
2008-07-23 |
2014-08-20 |
Hanmi Science Co., Ltd. |
A polypeptide complex comprising non-peptidyl polymer having three functional ends
|
|
DK3178835T3
(da)
*
|
2009-02-03 |
2019-06-24 |
Amunix Pharmaceuticals Inc |
Forlængede rekombinante polypeptider og sammensætninger omfattende samme
|
|
GB0914110D0
(en)
|
2009-08-12 |
2009-09-16 |
Medical Res Council |
Peptide libraries
|
|
KR20120092611A
(ko)
|
2009-09-30 |
2012-08-21 |
글락소 그룹 리미티드 |
연장된 반감기를 갖는 약물 융합체 및 컨쥬게이트
|
|
EP2494061B1
(en)
|
2009-10-29 |
2017-01-25 |
Janssen Biotech, Inc. |
Antibody glycosylation variants
|
|
US8637637B2
(en)
|
2010-01-12 |
2014-01-28 |
Bill Nai-Chau Sun |
Fc fusion proteins of human growth hormone
|
|
AR081066A1
(es)
|
2010-04-02 |
2012-06-06 |
Hanmi Holdings Co Ltd |
Conjugado de insulina donde se usa un fragmento de inmunoglobulina
|
|
DK2571510T3
(en)
|
2010-05-21 |
2018-11-19 |
Xl Protein Gmbh |
BIOSYNTHETIC PROLIN / ALANIN-RANDOM COIL POLYPEPTIDES AND THEIR APPLICATIONS
|
|
KR101337797B1
(ko)
|
2010-07-14 |
2013-12-06 |
한미사이언스 주식회사 |
지속형 인간 성장 호르몬 결합체 액상 제제
|
|
EP2694528A1
(en)
|
2011-04-05 |
2014-02-12 |
Martin-Protean, LLC |
Isolation of cysteine containing peptides
|
|
UA117901C2
(uk)
|
2011-07-06 |
2018-10-25 |
Ґенмаб Б.В. |
Спосіб посилення ефекторної функції вихідного поліпептиду, його варіанти та їх застосування
|
|
CN104302408B
(zh)
|
2012-02-27 |
2016-12-14 |
阿穆尼克斯运营公司 |
Xten缀合组合物和制造其的方法
|
|
US9545449B2
(en)
|
2012-05-11 |
2017-01-17 |
Advanced Proteone Therapeutics Inc. |
Site-specific labeling and targeted delivery of proteins for the treatment of cancer
|
|
US20160115216A1
(en)
|
2013-06-07 |
2016-04-28 |
Novo Nordisk A/S |
Method for Making Mature Insulin Polypeptides
|
|
WO2015038938A1
(en)
|
2013-09-13 |
2015-03-19 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
|
EP4053560A1
(en)
|
2013-11-26 |
2022-09-07 |
The Brigham and Women's Hospital, Inc. |
Compositions and methods for modulating an immune response
|
|
CN106068274A
(zh)
|
2014-03-05 |
2016-11-02 |
Ucb生物制药私人有限公司 |
多聚体Fc蛋白
|
|
US11279771B2
(en)
|
2014-09-17 |
2022-03-22 |
Novo Nordisk A/S |
Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (1-161)
|
|
WO2016133372A2
(ko)
|
2015-02-17 |
2016-08-25 |
한미약품 주식회사 |
지속형 인슐린 또는 이의 아날로그 결합체
|
|
AR105616A1
(es)
|
2015-05-07 |
2017-10-25 |
Lilly Co Eli |
Proteínas de fusión
|
|
EP3303380B1
(en)
|
2015-06-02 |
2020-01-15 |
Novo Nordisk A/S |
Insulins with polar recombinant extensions
|
|
ES2907651T3
(es)
|
2015-08-14 |
2022-04-25 |
Remegen Biosciences Inc |
Enlazadores covalentes en conjugados de anticuerpo-fármaco y métodos para obtener y usar los mismos
|
|
WO2017055582A1
(en)
|
2015-10-01 |
2017-04-06 |
Novo Nordisk A/S |
Protein conjugates
|
|
JP2020513019A
(ja)
|
2017-04-05 |
2020-04-30 |
ノヴォ ノルディスク アー／エス |
オリゴマー伸長インスリン−Ｆｃコンジュゲート
|